Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study
Authors
Keywords
Patisiran, RNA interference, Transthyretin-mediated familial amyloidotic polyneuropathy, Polyneuropathy, Hereditary disease, Genetic mutation, Phase II, Clinical trial
Journal
Orphanet Journal of Rare Diseases
Volume 10, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-09-03
DOI
10.1186/s13023-015-0326-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rapid progression of familial amyloidotic polyneuropathy
- (2015) David Adams et al. NEUROLOGY
- Liver Transplantation for Hereditary Transthyretin Amyloidosis
- (2015) Bo-Göran Ericzon et al. TRANSPLANTATION
- Repurposing Diflunisal for Familial Amyloid Polyneuropathy
- (2015) John L. Berk et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect on disability and safety of Tafamidis in late onset of Met30 transthyretin familial amyloid polyneuropathy
- (2013) P. Lozeron et al. EUROPEAN JOURNAL OF NEUROLOGY
- Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy
- (2013) Teresa Coelho et al. JOURNAL OF NEUROLOGY
- Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial
- (2013) Kevin Fitzgerald et al. LANCET
- Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis
- (2013) Teresa Coelho et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tafamidis for transthyretin familial amyloid polyneuropathy: A randomized, controlled trial
- (2012) T. Coelho et al. NEUROLOGY
- Long-term survival after liver transplantation in patients with familial amyloid polyneuropathy
- (2012) T. Yamashita et al. NEUROLOGY
- Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: Prediction and prevention
- (2011) Janos Szebeni et al. ADVANCED DRUG DELIVERY REVIEWS
- Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30)
- (2010) Gösta Holmgren et al. CLINICAL GENETICS
- Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms
- (2010) Akin Akinc et al. MOLECULAR THERAPY
- Progression of transthyretin amyloid neuropathy after liver transplantation
- (2010) J. J. Liepnieks et al. NEUROLOGY
- Cardiac amyloidosis in African Americans: Comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis
- (2009) Lawreen H. Connors et al. AMERICAN HEART JOURNAL
- Liver transplantation for familial amyloidotic polyneuropathy: Impact on Swedish patients' survival
- (2009) Sadahisa Okamoto et al. LIVER TRANSPLANTATION
- Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates
- (2008) M. Frank-Kamenetsky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started